TAG:

clinical mass spectrometry

September 9, 2013 “Intelligence: Late Breaking Lab News”

bioMérieux is on the move. Last week it announced that it would pay $450 million to purchase privately-held BioFire Diagnostics of Salt Lake City, Utah. BioFire has a solid tech- nology base in molecular diagnostics. It developed and currently markets its FilmArray…

Read More